Gerry Feldman, President of Oridion Capnography, commented that "The earliest possible warning of potential respiratory distress is key in sedated patients, and Microstream® provides the earliest indicator of ventilatory status. Clinical studies such as Dr. Deitch's have shown that Oridion Microstream® Capnography provides the most accurate monitoring of ventilation and improves patient safety."
For further Oridion information please contact
Alan Adler, Chairman and Chief Executive Officer
Walter Tabachnik, Chief Financial Officer
Elena Gerberg, Investor Relations
e-mail: investor (at) oridion (dot) com
phone: +972 2 589 9159
address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel
Oridion Systems Ltd. (www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.
Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream® technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.
Certain statements made
Copyright©2009 Vocus, Inc.
All rights reserved